452 related articles for article (PubMed ID: 4135113)
1. Influence of the mutation "diabetes" on insulin release and islet morphology in mice of different genetic backgrounds.
Boquist L; Hellman B; Lernmark A; Täljedal IB
J Cell Biol; 1974 Jul; 62(1):77-89. PubMed ID: 4135113
[TBL] [Abstract][Full Text] [Related]
2. Estrogenic restoration of functional pancreatic islet cytoarchitecture in diabetes (db/db) mutant C57BL/KsJ mice: relationship to estradiol localization, systemic glycemia, and persistent hyperinsulinemia.
Garris DR; Garris BL
Cell Tissue Res; 2005 Feb; 319(2):231-42. PubMed ID: 15654653
[TBL] [Abstract][Full Text] [Related]
3. Cytochemical analysis of pancreatic islet hypercytolipidemia following diabetes (db/db) and obese (ob/ob) mutation expression: influence of genomic background.
Garris DR; Garris BL
Pathobiology; 2004; 71(5):231-40. PubMed ID: 15459481
[TBL] [Abstract][Full Text] [Related]
4. Lack of long-term beta-cell glucotoxicity in vitro in pancreatic islets isolated from two mouse strains (C57BL/6J; C57BL/KsJ) with different sensitivities of the beta-cells to hyperglycaemia in vivo.
Svensson C; Sandler S; Hellerström C
J Endocrinol; 1993 Feb; 136(2):289-96. PubMed ID: 8459194
[TBL] [Abstract][Full Text] [Related]
5. Development of the insulin secretory defect in genetically diabetic (db/db) mouse.
Berglund O; Frankel BJ; Hellman B
Acta Endocrinol (Copenh); 1978 Mar; 87(3):543-51. PubMed ID: 343471
[TBL] [Abstract][Full Text] [Related]
6. Role of Ca2+ in impaired insulin release from islets of diabetic (C57BL/KsJ-db/db) mice.
Siegel EG; Wollheim CB; Sharp GW; Herberg L; Renold AE
Am J Physiol; 1980 Aug; 239(2):E132-8. PubMed ID: 6996492
[TBL] [Abstract][Full Text] [Related]
7. Characterization of CS-045, a new oral antidiabetic agent, II. Effects on glycemic control and pancreatic islet structure at a late stage of the diabetic syndrome in C57BL/KsJ-db/db mice.
Fujiwara T; Wada M; Fukuda K; Fukami M; Yoshioka S; Yoshioka T; Horikoshi H
Metabolism; 1991 Nov; 40(11):1213-8. PubMed ID: 1943750
[TBL] [Abstract][Full Text] [Related]
8. The dynamic insulin secretory response of isolated pancreatic islets of the diabetic mouse. Evidence for a gene dosage effect on insulin secretion.
Molina JM; Premdas FH; Klenck RE; Eddlestone G; Oldham SB; Lipson LG
Diabetes; 1984 Nov; 33(11):1120-3. PubMed ID: 6389229
[TBL] [Abstract][Full Text] [Related]
9. Positive effects of GLP-1 receptor activation with liraglutide on pancreatic islet morphology and metabolic control in C57BL/KsJ db/db mice with degenerative diabetes.
Moffett RC; Patterson S; Irwin N; Flatt PR
Diabetes Metab Res Rev; 2015 Mar; 31(3):248-55. PubMed ID: 25256010
[TBL] [Abstract][Full Text] [Related]
10. Pioglitazone improves insulin secretory capacity and prevents the loss of beta-cell mass in obese diabetic db/db mice: Possible protection of beta cells from oxidative stress.
Ishida H; Takizawa M; Ozawa S; Nakamichi Y; Yamaguchi S; Katsuta H; Tanaka T; Maruyama M; Katahira H; Yoshimoto K; Itagaki E; Nagamatsu S
Metabolism; 2004 Apr; 53(4):488-94. PubMed ID: 15045697
[TBL] [Abstract][Full Text] [Related]
11. Alteration of islet cell populations in spontaneously diabetic mice.
Baetens D; Stefan Y; Ravazzola M; Malaisse-Lagae F; Coleman DL; Orci L
Diabetes; 1978 Jan; 27(1):1-7. PubMed ID: 340309
[TBL] [Abstract][Full Text] [Related]
12. Structural and functional analysis of pancreatic islets preserved by pioglitazone in db/db mice.
Kawasaki F; Matsuda M; Kanda Y; Inoue H; Kaku K
Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E510-8. PubMed ID: 15522998
[TBL] [Abstract][Full Text] [Related]
13. Rectification of diabetic state in C57BL/KsJ-db/db mice by the implantation of pancreatic beta cell line MIN6.
Inada S; Kaneko S; Suzuki K; Miyazaki J; Asakura H; Fujiwara M
Diabetes Res Clin Pract; 1996 May; 32(3):125-33. PubMed ID: 8858200
[TBL] [Abstract][Full Text] [Related]
14. A fatty acid-induced decrease in pyruvate dehydrogenase activity is an important determinant of beta-cell dysfunction in the obese diabetic db/db mouse.
Zhou YP; Berggren PO; Grill V
Diabetes; 1996 May; 45(5):580-6. PubMed ID: 8621007
[TBL] [Abstract][Full Text] [Related]
15. Characterization of beta-cell specific function of isolated pancreatic islets from hyperglycemic C57BL/KsJ-db/db mice.
Wilke B; Besch W
Acta Biol Med Ger; 1982; 41(12):1157-61. PubMed ID: 6765159
[TBL] [Abstract][Full Text] [Related]
16. A temporal study of somatostatin secretion and its inhibitory effect in genetically diabetic mice (C57BL/KsJ-db/db).
Basabe JC; Pivetta OH; de Bruno LF; Cresto JC; Aparicio NJ
Endocrinology; 1983 Dec; 113(6):1927-34. PubMed ID: 6139272
[TBL] [Abstract][Full Text] [Related]
17. Function of the pancreatic B-cell during the development of hyperglycaemia in mice homozygous for the mutations "diabetes" (db) and "misty" (m).
Gunnarsson R
Diabetologia; 1975 Oct; 11(5):431-8. PubMed ID: 1103367
[TBL] [Abstract][Full Text] [Related]
18. Pioglitazone preserves pancreatic islet structure and insulin secretory function in three murine models of type 2 diabetes.
Diani AR; Sawada G; Wyse B; Murray FT; Khan M
Am J Physiol Endocrinol Metab; 2004 Jan; 286(1):E116-22. PubMed ID: 14532171
[TBL] [Abstract][Full Text] [Related]
19. Iodoacetamide-induced sensitization of the pancreatic beta-cells to glucose stimulation.
Hellman B; Idahl LA; Lernmark A; Sehlin J; Täljedal IB
Biochem J; 1973 Apr; 132(4):775-89. PubMed ID: 4198516
[TBL] [Abstract][Full Text] [Related]
20. Combination therapy with PPARgamma and PPARalpha agonists increases glucose-stimulated insulin secretion in db/db mice.
Yajima K; Hirose H; Fujita H; Seto Y; Fujita H; Ukeda K; Miyashita K; Kawai T; Yamamoto Y; Ogawa T; Yamada T; Saruta T
Am J Physiol Endocrinol Metab; 2003 May; 284(5):E966-71. PubMed ID: 12676649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
